Literature DB >> 7574513

Susceptibility of Encephalitozoon cuniculi to several drugs in vitro.

F F Franssen1, J T Lumeij, F van Knapen.   

Abstract

In the light of the increased incidence of human Encephalitozoon infections and the absence of an established treatment protocol, a simple in vitro testing method to compare activities of drugs against Encephalitozoon cuniculi was developed. With this in vitro method, the 50% inhibitory concentrations of fumagillin, thiabendazole, albendazole, oxibendazole, and propamidine isethionate for E. cuniculi in rabbit kidney cells were determined. Itraconazole, toltrazuril, metronidazole, ronidazole, and ganciclovir were ineffective in this testing system.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7574513      PMCID: PMC162724          DOI: 10.1128/AAC.39.6.1265

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  Control of nosema disease of honeybees with fumagillin.

Authors:  H KATZNELSON; C A JAMIESON
Journal:  Science       Date:  1952-01-18       Impact factor: 47.728

2.  Toltrazuril effective against a broad spectrum of protozoan parasites.

Authors:  H Mehlhorn; G Schmahl; A Haberkorn
Journal:  Parasitol Res       Date:  1988       Impact factor: 2.289

3.  Use of light microscopy to diagnose small-intestinal microsporidiosis in patients with AIDS.

Authors:  A C Rijpstra; E U Canning; R J Van Ketel; J K Eeftinck Schattenkerk; J J Laarman
Journal:  J Infect Dis       Date:  1988-04       Impact factor: 5.226

4.  Clinical significance of small-intestinal microsporidiosis in HIV-1-infected individuals.

Authors:  J K Eeftinck Schattenkerk; T van Gool; R J van Ketel; J F Bartelsman; C L Kuiken; W J Terpstra; P Reiss
Journal:  Lancet       Date:  1991-04-13       Impact factor: 79.321

5.  Treatment of intestinal microsporidiosis with albendazole in patients with AIDS.

Authors:  C Blanshard; D S Ellis; D G Tovey; S Dowell; B G Gazzard
Journal:  AIDS       Date:  1992-03       Impact factor: 4.177

6.  Sensitivity of Encephalitozoon cuniculi to various temperatures, disinfectants and drugs.

Authors:  T Waller
Journal:  Lab Anim       Date:  1979-07       Impact factor: 2.471

7.  Resolution of microsporidial epithelial keratopathy in a patient with AIDS.

Authors:  R W Yee; F O Tio; J A Martinez; K S Held; J A Shadduck; E S Didier
Journal:  Ophthalmology       Date:  1991-02       Impact factor: 12.079

8.  Microsporidial keratoconjunctivitis in a patient with AIDS.

Authors:  T W Metcalfe; R M Doran; P L Rowlands; A Curry; C J Lacey
Journal:  Br J Ophthalmol       Date:  1992-03       Impact factor: 4.638

9.  Some factors influencing the in vitro infectivity and replication of Encephalitozoon cuniculi.

Authors:  J A Shadduck; M B Polley
Journal:  J Protozool       Date:  1978-11

10.  In vitro and in vivo investigations of human microsporidia.

Authors:  E U Canning; W S Hollister
Journal:  J Protozool       Date:  1991 Nov-Dec
View more
  14 in total

Review 1.  Novel paradigms for drug discovery: computational multitarget screening.

Authors:  Ekachai Jenwitheesuk; Jeremy A Horst; Kasey L Rivas; Wesley C Van Voorhis; Ram Samudrala
Journal:  Trends Pharmacol Sci       Date:  2008-01-10       Impact factor: 14.819

2.  Testing intra-hemocelic injection of antimicrobials against Encephalitozoon sp. (Microsporidia) in an insect host.

Authors:  Shajahan Johny; Amanda S Nimmo; Mark A Fisher; Elizabeth S Inks; Ryan M Kirkpatrick; Philip A Miller; Adam L Johnson; Kanisha R Lites; Calli C Whitehouse; Douglas W Whitman
Journal:  Parasitol Res       Date:  2008-10-11       Impact factor: 2.289

3.  Novel synthetic polyamines are effective in the treatment of experimental microsporidiosis, an opportunistic AIDS-associated infection.

Authors:  Cyrus J Bacchi; Louis M Weiss; Schenella Lane; Benjamin Frydman; Aldonia Valasinas; Venodhar Reddy; Jerry S Sun; Laurence J Marton; Imitiaz A Khan; Magali Moretto; Nigel Yarlett; Murray Wittner
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

4.  In vitro susceptibilities of the microsporidia Encephalitozoon cuniculi, Encephalitozoon hellem, and Encephalitozoon intestinalis to albendazole and its sulfoxide and sulfone metabolites.

Authors:  O Ridoux; M Drancourt
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

5.  Investigations into microsporidian methionine aminopeptidase type 2: a therapeutic target for microsporidiosis.

Authors:  Hong Zhang; Huan Huang; Ann Cali; Peter M Takvorian; Xiaochuan Feng; Ghou Zhou; Louis M Weiss
Journal:  Folia Parasitol (Praha)       Date:  2005-05       Impact factor: 2.122

6.  Effects of albendazole, fumagillin, and TNP-470 on microsporidial replication in vitro.

Authors:  E S Didier
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

Review 7.  Molecular techniques for detection, species differentiation, and phylogenetic analysis of microsporidia.

Authors:  C Franzen; A Müller
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

8.  Effect of three drugs against Encephalitozoon cuniculi infection in immunosuppressed mice.

Authors:  Maria Anete Lallo; Lidiana F Vidoto da Costa; João Manoel de Castro
Journal:  Antimicrob Agents Chemother       Date:  2013-04-22       Impact factor: 5.191

Review 9.  Encephalitozoonosis in rabbits.

Authors:  Frank Künzel; Anja Joachim
Journal:  Parasitol Res       Date:  2009-11-17       Impact factor: 2.289

10.  Analysis of the beta-tubulin gene and morphological changes of the microsporidium Anncaliia algerae both suggest albendazole sensitivity.

Authors:  Marianita Santiana; Cyrilla Pau; Peter M Takvorian; Ann Cali
Journal:  J Eukaryot Microbiol       Date:  2014-09-15       Impact factor: 3.346

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.